Barclays’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $318K | Buy |
30,675
+16,306
| +113% | +$169K | ﹤0.01% | 3283 |
|
2025
Q1 | $190K | Sell |
14,369
-4,730
| -25% | -$62.5K | ﹤0.01% | 3357 |
|
2024
Q4 | $342K | Buy |
19,099
+7,488
| +64% | +$134K | ﹤0.01% | 3264 |
|
2024
Q3 | $188K | Buy |
11,611
+7,849
| +209% | +$127K | ﹤0.01% | 3519 |
|
2024
Q2 | $102K | Sell |
3,762
-203
| -5% | -$5.5K | ﹤0.01% | 3364 |
|
2024
Q1 | $78K | Sell |
3,965
-2,707
| -41% | -$53.3K | ﹤0.01% | 3723 |
|
2023
Q4 | $138K | Buy |
6,672
+4,683
| +235% | +$96.9K | ﹤0.01% | 3631 |
|
2023
Q3 | $63K | Sell |
1,989
-52
| -3% | -$1.65K | ﹤0.01% | 3498 |
|
2023
Q2 | $69K | Buy |
2,041
+774
| +61% | +$26.2K | ﹤0.01% | 3546 |
|
2023
Q1 | $53K | Hold |
1,267
| – | – | ﹤0.01% | 3775 |
|
2022
Q4 | $43K | Sell |
1,267
-38
| -3% | -$1.29K | ﹤0.01% | 3823 |
|
2022
Q3 | $64K | Sell |
1,305
-79
| -6% | -$3.87K | ﹤0.01% | 3578 |
|
2022
Q2 | $54K | Sell |
1,384
-513
| -27% | -$20K | ﹤0.01% | 3705 |
|
2022
Q1 | $70K | Sell |
1,897
-1,827
| -49% | -$67.4K | ﹤0.01% | 3841 |
|
2021
Q4 | $365K | Buy |
3,724
+2,487
| +201% | +$244K | ﹤0.01% | 2640 |
|
2021
Q3 | $155K | Buy |
1,237
+268
| +28% | +$33.6K | ﹤0.01% | 3084 |
|
2021
Q2 | $121K | Sell |
969
-1,305
| -57% | -$163K | ﹤0.01% | 3077 |
|
2021
Q1 | $309K | Buy |
2,274
+307
| +16% | +$41.7K | ﹤0.01% | 2932 |
|
2020
Q4 | $178K | Sell |
1,967
-581
| -23% | -$52.6K | ﹤0.01% | 2747 |
|
2020
Q3 | $190K | Buy |
2,548
+70
| +3% | +$5.22K | ﹤0.01% | 2769 |
|
2020
Q2 | $210K | Buy |
2,478
+1,241
| +100% | +$105K | ﹤0.01% | 2786 |
|
2020
Q1 | $89K | Buy |
+1,237
| New | +$89K | ﹤0.01% | 2875 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 4164 |
|
2019
Q3 | – | Sell |
-87
| Closed | -$4K | – | 4365 |
|
2019
Q2 | $4K | Sell |
87
-235
| -73% | -$10.8K | ﹤0.01% | 4102 |
|
2019
Q1 | $23K | Sell |
322
-100
| -24% | -$7.14K | ﹤0.01% | 3881 |
|
2018
Q4 | $34K | Buy |
422
+197
| +88% | +$15.9K | ﹤0.01% | 3268 |
|
2018
Q3 | $105K | Buy |
225
+181
| +411% | +$84.5K | ﹤0.01% | 3388 |
|
2018
Q2 | $17K | Sell |
44
-53
| -55% | -$20.5K | ﹤0.01% | 3706 |
|
2018
Q1 | $30K | Sell |
97
-4
| -4% | -$1.24K | ﹤0.01% | 3720 |
|
2017
Q4 | $30K | Buy |
101
+45
| +80% | +$13.4K | ﹤0.01% | 3559 |
|
2017
Q3 | $31K | Buy |
56
+4
| +8% | +$2.21K | ﹤0.01% | 3090 |
|
2017
Q2 | $31K | Buy |
52
+51
| +5,100% | +$30.4K | ﹤0.01% | 3159 |
|
2017
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4122 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 3961 |
|